$PLSH
Panacea Life Sciences Holdings Inc Stock $plsh

$plsh Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222022560 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$366.2K	$469.5K	$466.5K
YoY Change	-37.72%	49.75%	-23.25%
Cost Of Revenue	$318.9K	$331.5K	$1.654M
YoY Change	-79.5%	33.32%	17.73%
Gross Profit	$47.33K	$138.0K	-$1.187M
YoY Change	-104.89%	112.76%	48.96%
Gross Profit Margin	12.92%	29.39%	-254.56%
Selling, General & Admin	$261.5K	$204.7K	$460.6K
YoY Change	-10.02%	-67.05%	83.46%
% of Gross Profit	552.57%	148.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$421.7K	$409.9K	$424.0K
YoY Change	3.4%	-10.95%
% of Gross Profit	891.04%	297.09%
Operating Expenses	$1.436M	$1.378M	$460.5K
YoY Change	394.09%	-8.4%	83.45%
Operating Profit	-$1.389M	-$1.240M	-$1.648M
YoY Change	10.38%	-13.85%	57.22%
Interest Expense	$597.9K	$570.0K	-$1.446M
YoY Change	-125.8%	100.43%	-233.25%
% of Operating Profit
Other Income/Expense, Net	-$1.305M	-$721.8K	$311.8K
YoY Change	-624.7%	-149.21%
Pretax Income	-$2.694M	-$1.962M	-$2.782M
YoY Change	-12.81%	-7308.79%	-990.09%
Income Tax
% Of Pretax Income
Net Earnings	-$2.694M	-$1.962M	-$2.782M
YoY Change	-12.81%	-7308.79%	-990.09%
Net Earnings / Revenue	-735.55%	-417.87%	-596.45%
Basic Earnings Per Share	-$0.18	-$0.13	-$0.16
Diluted Earnings Per Share	-$181.3K	-$132.0K	-$188.5K
COMMON SHARES
Basic Shares Outstanding	14.97M shares	14.86M shares	16.92M shares
Diluted Shares Outstanding	14.86M shares	14.97M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.152M	$2.599M	$2.903M
YoY Change	-68.4%	-57.64%	14619.47%
Cash & Equivalents	$36.79K	$36.53K	$56.00K
Short-Term Investments	$1.116M	$2.562M	$2.847M
Other Short-Term Assets	$197.4K	$320.2K	$233.6K
YoY Change	1.97%	213.96%	2112.22%
Inventory	$4.412M	$4.480M	$4.325M
Prepaid Expenses
Receivables	$221.9K	$219.6K	$162.6K
Other Receivables	$500.0K	$500.0K	$500.0K
Total Short-Term Assets	$6.484M	$8.119M	$8.124M
YoY Change	-29.52%	-28.15%	19718.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.965M	$8.208M	$12.05M
YoY Change	-37.03%	-15.48%	70499.0%
Goodwill	$2.189M	$2.189M
YoY Change
Intangibles	$15.35K	$30.70K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$13.50M	$13.85M	$14.29M
YoY Change	-9.48%	12.25%	83591.33%
TOTAL ASSETS
Total Short-Term Assets	$6.484M	$8.119M	$8.124M
Total Long-Term Assets	$13.50M	$13.85M	$14.29M
Total Assets	$19.98M	$21.97M	$22.41M
YoY Change	-17.13%	-7.07%	38497.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.306M	$2.565M	$2.151M
YoY Change	56.4%	16.83%	13.49%
Accrued Expenses	$1.974M	$1.857M	$1.741M
YoY Change	-60.23%	746.23%	93.21%
Deferred Revenue
YoY Change
Short-Term Debt	$9.535M	$8.642M	$7.666M
YoY Change	50.98%	40.3%	5556.43%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.81M	$13.06M	$11.56M
YoY Change	8.33%	52.36%	238.71%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$3.531M	$3.480M	$6.672M
YoY Change	16.06%	14.36%
Total Long-Term Liabilities	$3.531M	$3.480M	$6.672M
YoY Change	16.06%	14.36%	3151.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.81M	$13.06M	$11.56M
Total Long-Term Liabilities	$3.531M	$3.480M	$6.672M
Total Liabilities	$20.42M	$19.71M	$18.23M
YoY Change	29.31%	69.68%	1039.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$24.20M	-$21.50M
YoY Change
Common Stock	$1.496K	$1.497K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$439.9K	$2.254M	$4.181M
YoY Change
Total Liabilities & Shareholders Equity	$19.98M	$21.97M	$22.41M
YoY Change	-17.13%	-7.07%	38497.66%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.694M	-$1.962M	-$2.782M
YoY Change	-12.81%	-7308.79%	-990.09%
Depreciation, Depletion And Amortization	$421.7K	$409.9K	$424.0K
YoY Change	3.4%	-10.95%
Cash From Operating Activities	-$711.1K	-$729.5K	-$436.0K
YoY Change	-5.5%	-61.89%	1615.34%
INVESTING ACTIVITIES
Capital Expenditures	-$127.4K	-$7.870K	-$9.730K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$46.83K
YoY Change	-100.0%	-82.59%
Cash From Investing Activities	-$127.4K	$38.96K	-$9.730K
YoY Change	-152.18%	-85.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	838.7K	671.0K	482.0K
YoY Change	113.84%	-60.46%	2309.95%
NET CHANGE
Cash From Operating Activities	-711.1K	-729.5K	-436.0K
Cash From Investing Activities	-127.4K	38.96K	-9.730K
Cash From Financing Activities	838.7K	671.0K	482.0K
Net Change In Cash	260.0	-19.46K	36.22K
YoY Change	-100.22%	-137.6%	-768.27%
FREE CASH FLOW
Cash From Operating Activities	-$711.1K	-$729.5K	-$436.0K
Capital Expenditures	-$127.4K	-$7.870K	-$9.730K
Free Cash Flow	-$583.7K	-$721.6K	-$426.3K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	EXDID	Employer Retention Credit EmployerRetentionCredit		usd
CY2021Q2	EXDID	Employer Retention Credit EmployerRetentionCredit		usd
	EXDID	Employer Retention Credit EmployerRetentionCredit		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001552189
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2021Q2	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss		usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss		usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss		usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	EXDID	Gain On Forgiveness Of Debt GainOnForgivenessOfDebt		usd
	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition		usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	EXDID	Proceeds From Payroll Protection Sba Loans ProceedsFromPayrollProtectionSBALoans		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	EXDID	Noncash Receivable Related Party NoncashReceivableRelatedParty		usd
	EXDID	Noncash Related Party Loan Repayment With Inventory NoncashRelatedPartyLoanRepaymentWithInventory		usd
	EXDID	Noncash Fixed Asset Disposal As Part Of Reverse Acquisition NoncashFixedAssetDisposalAsPartOfReverseAcquisition		usd
	EXDID	Conversion Of Preferred Shares To Note Payable ConversionOfPreferredSharesToNotePayable		usd
	EXDID	Issuance Of Common Stock For Services Non Cash IssuanceOfCommonStockForServicesNonCash		usd
	EXDID	Liabilities From Acquisition Non Cash LiabilitiesFromAcquisitionNonCash		usd
	us-gaap	Notes Reduction NotesReduction		usd
	EXDID	Preferred Stock Series B One Non Cash PreferredStockSeriesBOneNonCash		usd
	EXDID	Preferred Stock Series B Two Non Cash PreferredStockSeriesBTwoNonCash		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021Q4	EXDID	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Equity Instruments Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsAggregateIntrinsicValueOutstanding		usd
	EXDID	Share Based Compensation Arrangement By Share Based Payment Award Non Option Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	EXDID	Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisedInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations		shares
	EXDID	Share Based Compensation Arrangement By Share Based Payment Award Non Option Forfeited Or Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionForfeitedOrExpiredInPeriodWeightedAverageExercisePrice
CY2022Q2	EXDID	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Equity Instruments Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsAggregateIntrinsicValueOutstanding		usd
	EXDID	Share Based Compensation Arrangement By Share Based Payment Award Non Option Vested And Exercisable In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionVestedAndExercisableInPeriodWeightedAverageIntrinsicValue
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38190
	dei	Entity Registrant Name EntityRegistrantName	Panacea Life Sciences Holdings, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1085858
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5910 S University Blvd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	C18-193
	dei	Entity Address City Or Town EntityAddressCityOrTown	Greenwood Village
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80121
	dei	City Area Code CityAreaCode	800
	dei	Local Phone Number LocalPhoneNumber	985-0515
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14965317	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36529	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19774	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	219551	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	244496	usd
CY2022Q2	us-gaap	Other Receivables OtherReceivables	500000	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	500000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	4480479	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	4264277	usd
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2562390	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	3791483	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	320151	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	278328	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	8119100	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	9098358	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3420033	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3595100	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8207578	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8839982	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30701	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	61401	usd
CY2022Q2	us-gaap	Goodwill Goodwill	2188810	usd
CY2021Q4	us-gaap	Goodwill Goodwill	2188810	usd
CY2022Q2	us-gaap	Assets Assets	21966222	usd
CY2021Q4	us-gaap	Assets Assets	23783651	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2565361	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1685825	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1857125	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1624090	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	7594893	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	6441866	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	947586	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	220005	usd
CY2022Q2	EXDID	Paycheck Protection Loan PaycheckProtectionLoan	99100	usd
CY2021Q4	EXDID	Paycheck Protection Loan PaycheckProtectionLoan	99100	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	13064065	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10070886	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3168620	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3347335	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3479543	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3263028	usd
CY2022Q2	us-gaap	Liabilities Liabilities	19712228	usd
CY2021Q4	us-gaap	Liabilities Liabilities	16681249	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14965317	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14965317	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1407708	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1407708	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	1497	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1407	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23760704	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23865155	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21509060	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16765013	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2253994	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	7102402	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21966222	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23783651	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	469472	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	313496	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	935946	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	825634	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	331500	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	248646	usd
	us-gaap	Cost Of Revenue CostOfRevenue	697591	usd
	us-gaap	Cost Of Revenue CostOfRevenue	578483	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	137972	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	64850	usd
	us-gaap	Gross Profit GrossProfit	238355	usd
	us-gaap	Gross Profit GrossProfit	247151	usd
CY2022Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1173294	usd
CY2021Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1169040	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2461111	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2156973	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	204680	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	335224	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	665230	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	621268	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1377974	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1504264	usd
	us-gaap	Operating Expenses OperatingExpenses	3126341	usd
	us-gaap	Operating Expenses OperatingExpenses	2778241	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1240002	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1439414	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2887986	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2531090	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	569985	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	284381	usd
	us-gaap	Interest Expense InterestExpense	1071280	usd
	us-gaap	Interest Expense InterestExpense	606944	usd
CY2022Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-260273	usd
CY2021Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1738002	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-1205077	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	3151751	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	22816	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	22816	usd
CY2022Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	27598	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	27598	usd
	EXDID	Employer Retention Credit EmployerRetentionCredit	253791	usd
CY2022Q2	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	58045	usd
CY2021Q2	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	67317	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	116091	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	162918	usd
CY2021Q2	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-297351	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-297351	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	243041	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	518580	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-721799	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1466628	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1856061	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2928954	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1961801	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	27214	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4744047	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	397864	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1961801	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	27214	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4744047	usd
	us-gaap	Net Income Loss NetIncomeLoss	397864	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14862077	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16915706	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14862077	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16915706	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	4180794	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	35000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1961801	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2253994	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	7102402	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	55000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-159362	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4744047	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2253994	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	7078949	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4378992	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	27214	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	11485155	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6708299	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4378992	usd
	us-gaap	Net Income Loss NetIncomeLoss	397864	usd
	us-gaap	Net Income Loss NetIncomeLoss	397864	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	11485155	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4744047	usd
	us-gaap	Net Income Loss NetIncomeLoss	397864	usd
	us-gaap	Depreciation Depreciation	818586	usd
	us-gaap	Depreciation Depreciation	887838	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	22816	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-1205077	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	3151751	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-297351	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	30700	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	30701	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	568219	usd
	EXDID	Gain On Forgiveness Of Debt GainOnForgivenessOfDebt	518580	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-24945	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	142319	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	216202	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	556972	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	41823	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	74593	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	982474	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	661376	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	229387	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	229386	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1165500	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1939699	usd
	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	9157	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	46832	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	446026	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17604	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	186197	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	29228	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	268986	usd
	EXDID	Proceeds From Payroll Protection Sba Loans ProceedsFromPayrollProtectionSBALoans	243041	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	540848	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	135000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1693875	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1609000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1153027	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1717041	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	16755	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	46328	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19774	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	84379	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	36529	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	130707	usd
	EXDID	Noncash Receivable Related Party NoncashReceivableRelatedParty	-500000	usd
	EXDID	Noncash Related Party Loan Repayment With Inventory NoncashRelatedPartyLoanRepaymentWithInventory	4693367	usd
	EXDID	Noncash Fixed Asset Disposal As Part Of Reverse Acquisition NoncashFixedAssetDisposalAsPartOfReverseAcquisition	3058457	usd
	EXDID	Conversion Of Preferred Shares To Note Payable ConversionOfPreferredSharesToNotePayable	385000	usd
	EXDID	Issuance Of Common Stock For Services Non Cash IssuanceOfCommonStockForServicesNonCash	55000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	168578	usd
	EXDID	Liabilities From Acquisition Non Cash LiabilitiesFromAcquisitionNonCash	1096782	usd
	us-gaap	Notes Reduction NotesReduction	12718441	usd
	EXDID	Preferred Stock Series B One Non Cash PreferredStockSeriesBOneNonCash	150	usd
	EXDID	Preferred Stock Series B Two Non Cash PreferredStockSeriesBTwoNonCash	600	usd
	us-gaap	Stock Issued1 StockIssued1	4369085	usd
	EXDID	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	1182260	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21500000	usd
CY2022Q2	EXDID	Cash And Liquid Stock CashAndLiquidStock	2599000	usd
CY2021Q4	EXDID	Convertible Notes Payable And Warrant Financing ConvertibleNotesPayableAndWarrantFinancing	1100000	usd
CY2021Q4	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zbwsH8dSGjKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zRW7C3y98XZc">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Unaudited Condensed Consolidated Financial Statements have been prepared in conformity with US GAAP and required management of the Company to make estimates and assumptions in preparation of these statements. Actual results may differ significantly from those estimates. Significant estimates made by management include but are not limited to the useful life of property and equipment, incremental borrowing rate used in the calculation of right of use asset and lease liability, reserves for inventory, allowance for doubtful accounts, revenue allocations, valuation allowance on deferred tax assets, assumptions used in assessing impairment of long-term assets, assumptions used in the calculation of net realizable value of inventory and fair value of non-cash equity transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2562390	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	455622	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5850	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-28 reverse stock split
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5133541	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1862078	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.51
CY2022Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	2562390	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3719483	usd
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3.29
	EXDID	Sale Securities Debt Securities SaleSecuritiesDebtSecurities	46833	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	22816	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	3791483	usd
	EXDID	Sale Securities Debt Securities SaleSecuritiesDebtSecurities	46833	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8839982	usd
CY2022Q2	us-gaap	Depreciation Depreciation	409895	usd
	us-gaap	Depreciation Depreciation	818586	usd
CY2021Q2	us-gaap	Depreciation Depreciation	460316	usd
	us-gaap	Depreciation Depreciation	887838	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M12D
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2022Q2	us-gaap	Goodwill Goodwill	2188810	usd
CY2021Q4	us-gaap	Goodwill Goodwill	2188810	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	307001	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	307001	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	276300	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	245600	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30701	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	61401	usd
	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	In determining the leases classification, the Company assesses among other criteria: (i) 75% or more of the remaining economic life of the underlying asset is a major part of the remaining economic life of that underlying asset; and (ii) 90% or more of the fair value of the underlying asset comprises substantially all of the fair value of the underlying asset
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y6M
CY2022Q2	EXDID	Customer Advances Payments CustomerAdvancesPayments	196284	usd
CY2021Q4	EXDID	Customer Advances Payments CustomerAdvancesPayments	24585	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	196491	shares
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24585	usd
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	121300	usd
	EXDID	Payments Received For Unearned Revenue PaymentsReceivedForUnearnedRevenue	181439	usd
CY2021	EXDID	Payments Received For Unearned Revenue PaymentsReceivedForUnearnedRevenue	41465	usd
	EXDID	Revenue Earned Amount RevenueEarnedAmount	9740	usd
CY2021	EXDID	Revenue Earned Amount RevenueEarnedAmount	138180	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	196284	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24585	usd
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	114693	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	114693	usd
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	229386	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	229386	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	225555	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12879353	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12702295	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4671775	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3862313	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8207578	usd
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1002084	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	970393	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1649703	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1466763	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1813143	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1805779	usd
CY2022Q2	EXDID	Packaging Supplies PackagingSupplies	15549	usd
CY2021Q4	EXDID	Packaging Supplies PackagingSupplies	15549	usd
CY2021Q4	EXDID	Trading Goods TradingGoods	5793	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	4480479	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	4264277	usd
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2030-12-31
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2030-12-31
CY2022Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P3Y
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	460178	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	464780	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	469427	usd
CY2022Q2	EXDID	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	1925123	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4000685	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	479529	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3521156	usd
CY2022Q2	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.80	pure
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	7594893	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	6441866	usd
CY2022Q2	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent	3479543	usd
CY2021Q4	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent	3263028	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	196491	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.51
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M12D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	196491	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.51
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y8M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	56377	shares
CY2021Q4	EXDID	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Number Of Share ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageNumberOfShare	13.64
	EXDID	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm	P2Y3D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	275000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	331377	shares
CY2022Q2	EXDID	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Number Of Share ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageNumberOfShare	3.48
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y1M28D
CY2022Q2	EXDID	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	331377	shares
CY2022Q2	EXDID	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	3.48
	EXDID	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm	P4Y1M28D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	107993	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	107993	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001

Files In Submission

Name	View Source	Status
0001493152-22-022560-index-headers.html	Edgar Link	pending
0001493152-22-022560-index.html	Edgar Link	pending
0001493152-22-022560.txt	Edgar Link	pending
0001493152-22-022560-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
exdid-20220630.xsd	Edgar Link	pending
exdid-20220630_def.xml	Edgar Link	unprocessable
exdid-20220630_lab.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
exdid-20220630_cal.xml	Edgar Link	unprocessable
exdid-20220630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLSH
Panacea Life Sciences Holdings Inc Stock $plsh

2022 Q3 Form 10-Q Financial Statement

#000149315222022560 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLSH Panacea Life Sciences Holdings Inc Stock $plsh

2022 Q3 Form 10-Q Financial Statement

#000149315222022560 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLSH
Panacea Life Sciences Holdings Inc Stock $plsh